Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neoplasms × pomalidomide × Clear all

Phase

Status

Terminated 4 Active not recruiting 3 Unknown 1 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 50 Recurrence 16 Neoplasms, Plasma Cell 5 Myeloproliferative Disorders 3 Renal Insufficiency 2 Primary Myelofibrosis 2 Polycythemia Vera 2 Plasmacytoma 2 Immunoglobulin Light-chain Amyloidosis 2 Central Nervous System Neoplasms 2 Waldenstrom Macroglobulinemia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Thrombocythemia, Essential 1 Sarcoma, Kaposi 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Optic Nerve Glioma 1 Neurofibromatosis 1 1 Neoplasms 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Plasma Cell 1 Leukemia, Myeloid, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Glioma 1 Ependymoma 1 Disease Progression 1 Disease 1 Chromosome 17 deletion 1 Brain Neoplasms 1

Interventions

Gemcitabine 84 Paclitaxel 75 Carboplatin 69 Bevacizumab 67 Surveys and Questionnaires 58 Docetaxel 58 pembrolizumab 57 Cisplatin 54 Exercise 41 Capecitabine 40 Cyclophosphamide 39 Sorafenib 36 Nivolumab 35 Fluorouracil 35 Irinotecan 33 Pemetrexed 32 Dexamethasone 30 Radiotherapy 28 Blood Specimen Collection 28 Erlotinib Hydrochloride 27 Oxaliplatin 26 Leucovorin 26 Cetuximab 24 Doxorubicin 23 130-nm albumin-bound paclitaxel 23 Sunitinib 22 Methods 22 Albumin-Bound Paclitaxel 22 Therapeutics 21 Standard of Care 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01946477 2025-06-06

POM MM 014

Celgene

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasmacytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡